191 related articles for article (PubMed ID: 24424334)
1. Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.
Boehme AK; Kapoor N; Albright KC; Lyerly MJ; Rawal PV; Bavarsad Shahripour R; Alvi M; Houston JT; Sisson A; Beasley TM; Alexandrov AW; Alexandrov AV; Miller DW
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e271-6. PubMed ID: 24424334
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome.
Boehme AK; Kapoor N; Albright KC; Lyerly MJ; Rawal PV; Bavarsad Shahripour R; Alvi M; Houston JT; Sisson A; Beasley TM; Alexandrov AW; Alexandrov AV; Miller DW
Stroke; 2013 Aug; 44(8):2321-3. PubMed ID: 23704110
[TBL] [Abstract][Full Text] [Related]
3. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
4. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
[TBL] [Abstract][Full Text] [Related]
5. Impact of systemic inflammatory response syndrome on acute ischemic stroke patients treated with mechanical thrombectomy.
Jafari M; Katlowitz K; De la Garza C; Sellers A; Moore S; Hall H; Desai A; Singh V; Damani R
J Neurol Sci; 2021 Nov; 430():119988. PubMed ID: 34547616
[TBL] [Abstract][Full Text] [Related]
6. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
7. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
[TBL] [Abstract][Full Text] [Related]
8. Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator-Ineligible Patients.
Rebello LC; Haussen DC; Grossberg JA; Belagaje S; Lima A; Anderson A; Frankel MR; Nogueira RG
Stroke; 2016 Apr; 47(4):1131-4. PubMed ID: 26906918
[TBL] [Abstract][Full Text] [Related]
9. The effect of metabolic syndrome and obesity on outcomes of acute ischemic stroke patients treated with systemic thrombolysis.
Bas DF; Ozdemir AO
J Neurol Sci; 2017 Dec; 383():1-4. PubMed ID: 29246591
[TBL] [Abstract][Full Text] [Related]
10. Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke.
Prabhakaran S; Jovin TG; Tayal AH; Hussain MS; Nguyen TN; Sheth KN; Terry JB; Nogueira RG; Horev A; Gandhi D; Wisco D; Glenn BA; Ludwig B; Clemmons PF; Cronin CA; Tian M; Liebeskind D; Zaidat OO; Castonguay AC; Martin C; Mueller-Kronast N; English JD; Linfante I; Malisch TW; Gupta R
Cerebrovasc Dis; 2014; 37(5):356-63. PubMed ID: 24942008
[TBL] [Abstract][Full Text] [Related]
11. Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion.
LaBuzetta JN; Yoo AJ; Ali S; Fitzpatrick K; Leslie-Mazwi T; Hirsch JA; Schwamm L; Rost N
J Stroke Cerebrovasc Dis; 2014; 23(10):2527-2532. PubMed ID: 25238927
[TBL] [Abstract][Full Text] [Related]
12. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
13. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
14. Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke.
Sarraj A; Albright K; Barreto AD; Boehme AK; Sitton CW; Choi J; Lutzker SL; Sun CH; Bibars W; Nguyen CB; Mir O; Vahidy F; Wu TC; Lopez GA; Gonzales NR; Edgell R; Martin-Schild S; Hallevi H; Chen PR; Dannenbaum M; Saver JL; Liebeskind DS; Nogueira RG; Gupta R; Grotta JC; Savitz SI
Stroke; 2013 Dec; 44(12):3324-30. PubMed ID: 23929748
[TBL] [Abstract][Full Text] [Related]
15. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke.
Faigle R; Sharrief A; Marsh EB; Llinas RH; Urrutia VC
PLoS One; 2014; 9(2):e88652. PubMed ID: 24533130
[TBL] [Abstract][Full Text] [Related]
16. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
18. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke.
Chalela JA; Kasner SE; Jauch EC; Pancioli AM
Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672
[TBL] [Abstract][Full Text] [Related]
19. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
[TBL] [Abstract][Full Text] [Related]
20. Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke?
Boehme AK; Kumar AD; Lyerly MJ; Gillette MA; Siegler JE; Albright KC; Beasley TM; Martin-Schild S
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1939-43. PubMed ID: 24784010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
